← FDA Drug Approvals (Drugs@FDA)

EZETIMIBE AND SIMVASTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2017-04-26

Drug application

FDA Application #

ANDA202968

Application type

Abbreviated New Drug Application (Generic)

Brand name

EZETIMIBE AND SIMVASTATIN

Generic name

Ezetimibe

Active ingredients

EZETIMIBE; SIMVASTATIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

WATSON LABS INC

First approval

2017-04-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown